Rx · Prescription onlyInjected under the skin

Semaglutide + Glycine + B12

Your plan

1 vial · lasts 4 weeks · 2.5 mg semaglutide, set by your clinician

You'll see the price in your assessment

  • Medication, clinician care and dose adjustments, all in one price.

A licensed clinician on our care team reviews every request and prescribes only when it's clinically appropriate.

FDA status: Compounded medication, not FDA-approved. Its active ingredient, semaglutide, is also in the FDA-approved drugs Ozempic and Wegovy; this compounded version is not one of them.

What it's for

Who it's for

People who want semaglutide with both add-ons in one vial instead of choosing between them.

How it's different

Same semaglutide, one concentration only: your clinician adjusts the dose by the units you draw, not by changing vials.

How it works

This combination pairs semaglutide's appetite-suppressing effect with glycine's muscle-supporting and sleep-promoting properties, and B12 for sustained energy. Glycine is the simplest amino acid and supports collagen synthesis and sleep; B12 is essential for nerve and energy metabolism.

How to use it and what arrives

1 vial · lasts 4 weeks

10 mg (5 mg / 5 mg / 1 mg/mL) · 2 mL vial

How
Injected under the skin
How often
Once a week

Good to know

Read the units on your label every time the dose changes; the vial looks the same but the line on the syringe moves.

What the research shows

Semaglutide is a GLP-1 receptor agonist. Its evidence comes from large randomized trials in adults with obesity, nearly all with the injected 2.4 mg weekly dose.

  1. Weight

    about 15%

    STEP 1: 1,961 adults with obesity or overweight and no diabetes, 68 weeks of weekly injections plus lifestyle advice. Mean weight change was -14.9% with semaglutide and -2.4% with placebo.

    STEP 1, NEJM 2021
  2. Two years

    about 15%

    STEP 5: 304 adults, 104 weeks of weekly 2.4 mg injections with behavioral support. Mean change was -15.2% with semaglutide and -2.6% with placebo.

    STEP 5, Nature Medicine 2022
  3. Heart events

    20% fewer events

    SELECT: 17,604 adults aged 45 and older with overweight or obesity and existing heart disease but no diabetes, followed about 40 months. Major cardiovascular events were 6.5% on 2.4 mg weekly and 8.0% on placebo (hazard ratio 0.80).

    SELECT, NEJM 2023

Trial results are for the injected 2.4 mg weekly product at the dose studied. They are averages, not predictions for one person. Compounded versions were not studied in these trials, and no trial has tested the sublingual (dissolve-under-the-tongue) form. The oral trial OASIS 4 (NEJM 2025, doi 10.1056/NEJMoa2500969) tested a 25 mg tablet swallowed, not a sublingual one.

What this does not say

  • The trials ran 68 to 104 weeks. They do not show what happens over the long term after treatment is stopped.
  • Nausea, diarrhea and vomiting were the most common side effects. In SELECT, 16.6% of people on semaglutide stopped the trial drug for adverse events, against 8.2% on placebo.
  • SELECT and STEP trials were funded by the manufacturer; the figures are for brand-name semaglutide in trial conditions.

Sources

  1. Semaglutide for weight loss (STEP 1): once-weekly GLP-1 resulted in mean 15% weight loss over 68 weeks. NEJM, 2021 (Wilding JPH et al.)
  2. L-carnitine supplementation improves energy metabolism and exercise performance in metabolic studies. Nutrients, 2021 (Malaguarnera M)
Read the full research

Safety

FDA status: Compounded medication, not FDA-approved. Its active ingredient, semaglutide, is also in the FDA-approved drugs Ozempic and Wegovy; this compounded version is not one of them.

Side effects and precautions

  • Semaglutide plus additives carries the safety profile of semaglutide itself: nausea, vomiting, diarrhea, constipation, reduced appetite, fatigue, and injection-site reactions are common in early weeks.
  • The additives (L-carnitine, methylcobalamin, glycine) are generally well-tolerated.
  • Not for pregnancy or breastfeeding, or with active pancreatitis.

Get care right away

  • Stop and seek care for severe abdominal pain, allergic reactions, or signs of pancreatitis.

When it isn't prescribed

  • Do not use with medullary thyroid carcinoma history or MEN 2.

Tell your clinician about all medications, diabetes drugs, and any kidney or pancreatic disease.

Questions

Is this better than semaglutide alone?

Not necessarily 'better,' but different. Semaglutide alone works well for many. This combination adds sleep and energy support. If you struggle with fatigue or poor sleep during weight loss, the additions may help. Your clinician will guide the choice.

Do I need all three additives?

Not necessarily. Your clinician will suggest the combination that matches your needs. If fatigue is your main concern, B12 and L-carnitine help. If sleep is the issue, glycine is the focus. You can change your combination over time.

Are additives safe long-term?

Yes. B12, glycine, and L-carnitine are natural compounds your body uses daily. They are safe at the doses used here, even for years of use. Your clinician monitors you at regular check-ins.

What if additives don't help?

Some people feel a difference immediately; others take weeks. If you don't notice energy or sleep improvements after 4–6 weeks, your clinician may adjust doses or try a different additive combination.

Can I combine with other supplements?

Tell your clinician about all supplements you take. Most are safe with semaglutide, but some interactions require monitoring or timing adjustments.

Still have a question? Message our team

Ready to start with Semaglutide + Glycine + B12?

  • Free shipping on every order
  • No membership fee
  • Same price at every dose
  • HSA and FSA accepted

More options in this area